Patents by Inventor Yi-Te Yo

Yi-Te Yo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Unique Interferon Alpha 2B And New Method Of Making Thereof
    Publication number: 20260167690
    Abstract: A composition and a new method of manufacturing and producing such composition including modified interferon alpha 2 b, modified acetylated interferon alpha 2 b, and/or a mixture thereof is disclosed herein.
    Type: Application
    Filed: October 17, 2025
    Publication date: June 18, 2026
    Applicant: PharmaEssentia Corporation
    Inventors: Ko-Chung Lin, Ming-Pin Hsu, Yu-Kuei Tsai, Yi-Te Yo, Jiing-Guang Chuang, Shin-Jye Lee
  • Mixture Of Interferon Alpha 2B With Other Modified Sequences Thereof
    Publication number: 20260109749
    Abstract: A composition and a new method of manufacturing and producing such composition including modified interferon alpha 2 b with deamidated amino acids is disclosed herein.
    Type: Application
    Filed: October 17, 2025
    Publication date: April 23, 2026
    Applicant: PharmaEssentia Corporation
    Inventors: Ko-Chung Lin, Ming-Pin Hsu, Yu-Kuei Tsai, Yi-Te Yo, Jiing-Guang Chuang, Shin-Jye Lee
  • Mixture Of Interferon Alpha 2B With Modified Sequences Thereof
    Publication number: 20260109750
    Abstract: This invention relates to use of interferon-polymer conjugates described in the specification to treat idiopathic myelofibrosis, polycythaemia vera and essential thrombocythaemia.
    Type: Application
    Filed: October 17, 2025
    Publication date: April 23, 2026
    Applicant: PharmaEssentia Corporation
    Inventors: Ko-Chung Lin, Ming-Pin Hsu, Yu-Kuei Tsai, Yi-Te Yo, Jiing-Guang Chuang, Shin-Jye Lee
  • UNIQUE PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR, METHODS OF USE AND PREPARATION THEREOF
    Publication number: 20250269045
    Abstract: A uniquely PEGylated, stable granulocyte colony stimulating factor (G-CSF) with unexpected properties is disclosed herein. The method of making and using such GCSF are also described. The unique molecule exhibits unexpectedly longer pharmacokinetics and pharmacodynamics profile than reference standard on the market. The molecule also demonstrates safety for use.
    Type: Application
    Filed: February 17, 2025
    Publication date: August 28, 2025
    Applicant: PharmaEssentia Corporation
    Inventors: Ko-Chung Lin, Shih-Long Yan, Yi-Te Yo, Shin-Jye Lee